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Abstract
Objective: Neurofibromatosis type 1 (NF1) is an autosomal dominant inherited disease. Although only a minority 
of NF1 patients develops malignancy as a complication of the disorder, cancer (mainly represented by tumors 
involving the nervous system) remains an important cause of morbidity and mortality. A case of the rare association 
between adenocarcinoma of the Vater ampulla and NF-1 is here reported. The patient accepted Whipple operation. 
Histologic analysis of the whole surgical specimen revealed an adenocarcinoma limited to the ampulla of Vater, 
without lymphonodal involvement.
Methods: A study of the possible presence of genetic alterations, which could demonstrate a molecular correlation 
between NF-1 and periampullary epithelial neoplasms, was performed using the intragenic NF1 microsatellites.
Results: Adenocarcinoma sample retained heterozygosity for the informative microsatellites; furthermore, 
microsatellite analysis was unable to detect any LOH involving the NF1 gene.
Conclusion: Our results suggest that Ampulla’s adenocarcinomas are an occasional event in NF1, accordingly 
to the epithelial but not neuroectodermical origin of this tumour.
Keywords: Ampullary adenocarcinoma; NF1; Vater ampulla; 
Pancreatoduodenectomy; von Recklinghausen’s disease
Introduction
Neurofibromatosis type 1 (NF1), formerly known as the peripheral 
form of neurofibromatosis, is an autosomal dominant inherited disease 
with a high rate of penetrance, that affects 1 in every 3500 live births. 
Caused by mutation in the NF1 gene, NF1 is characterized by multiple 
cafè-au-lait spots, peripheral neurofibromas, axillary and/or inguinal 
freckling, and Lisch nodules. The NF1 gene, located on 17q11.2, is a 
tumor suppressor gene; both copies of the gene are inactivated in benign 
and malignant NF1-associated tumors [1]. Loss of Heterozygosity 
(LOH) in the NF1 region is associated with peripheral and plexiform 
neurofibromas development, and can also be found in NF1-associated 
malignant peripheral nerve sheath tumors [2].
Although only a minority of NF1 patients develops malignancy 
as a complication of the disorder, cancer remains an important 
cause of morbidity and mortality. Malignancies develop in 3-15% 
of NF1 patients and are mainly represented by tumors involving the 
nervous system. However, neoplasms can arise in several organs, 
including the gastrointestinal tract, larynx, blood vessels and heart. 
The gastrointestinal involvement in NF1 may include: a) hyperplastic 
lesions of gut neural tissue, b) gastrointestinal stromal tumors, c) 
endocrine cell tumors of the duodenum and periampullary region d) a 
miscellaneous group of other tumors [3]. A case of the rare association 
between adenocarcinoma of the Vater ampulla and NF-1 is here 
reported and the study of the possible presence of genetic alterations, 
which could demonstrate a molecular correlation between NF-1 and 
periampullary epithelial neoplasms is also illustrated.
Material and Methods
Case reports
A 45-year-old white man, affected by NF1, came to our observation 
with a 2-week history of jaundice and epigastric pain. He had multiple 
subcutaneous neurofibromas, multiple cafè-au-lait spots and bone 
deformities (Figure 1a). His family history included two daughters 
Figure1: Panel A: Subcutaneous neurofibroma and multiple cafè-au-lait spots 
on the thorax of the present case; Panel B: A 15 mm solid mass of the ampulla 
of Vater, protruding into the duodenum detected by TC examination; Panel 
C: Operating specimen after Whipple operation; Panel D: The neopalsia was 
histologically formed by tubular glands with some areas with a cribriform pattern 
(intestinal-type adenocarcinoma).
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diseases: neurofibromatosis 1 (NF1) and neurofibromatosis 2 (NF2). 
NF1 is associated with deletions, insertions or mutations of the NF1 
gene, a tumor suppressor gene located in the pericentromeric region 
of chromosome 17q11.2. Since only half of the patients affected with 
this disease have other affected family members, the disease in the 
remaining patients is determined by new mutations, with the highest 
estimated mutation rate for a dominant inherited trait. Although NF1 
is considered to be completely penetrant, no recurring mutations have 
been identified, and the diagnosis is based on clinical criteria [6]. 
Gastrointestinal involvement has been documented in approximately 
25% of NF1 patients. Most gastrointestinal tumors are represented by 
neurofibromas, ganglioneuromas, paragangliomas and neurilemomas, 
but their real incidence is uncertain because the diagnosis is suspected 
only in symptomatic patients. Gastrointestinal stromal tumors (GIST) 
are the digestive tumors most frequently associated with NF1, tend to 
be multiple and are generally considered as noncoincidental because 
of their neuroectodermical origin. Carcinoid tumors have also been 
described in NF1, and the association is specific, almost certainly 
because of their neuroendocrine origin. An unusual feature of the NF1-
associated carcinoids is their predilection for duodenum and ampulla 
of Vater, an uncommon site in the general population.
The association of NF1 and periampullary neoplasms is a 
well-known finding and carcinoids are mostly represented in this 
association. Adenocarcinoma of the ampulla of Vater is a relatively 
uncommon neoplasm, which accounts for approximately 6% of the 
periampullary tumors. It has an incidence of approximately 5.7 cases 
per million population per year and a more favorable prognosis after 
curative surgery than adenocarcinomas with pancreatic or bile duct 
involvement. The most extensive review of tumors of the periampullary 
region in patients with NF1, up to now available in the english literature, 
performed in 1989, collected 37 cases of periampullary neoplasms 
but included only 3 epithelial tumors, one of the pancreas, one of 
the duodenum and one of ampulla of Vater [7]. Costi and coll, were 
able to perform the most extensive review of epithelial tumors of the 
periampullary region in NF1 patients, collecting 12 cases.
After a detailed analysis of the literature we were able to collected 
16 cases in 15 NF1 patients affected with ampullary or peri-ampullary 
carcinomas or adenocarcinomas (Table 1), including the present case. 
These tumors were cited in the ampulla of Vater in 7 cases [8-12] 
including the present case, in the duodenum in 5 cases [7,13-15], in 
the head of the pancreas in 3 cases [16-18] and in the bile duct in 1 case 
[18]. From this analysis it is clear that the rare association between NF-1 
and adenocarcinomas of the periampullary region is equally distributed 
between sexes, seven males, six women and two patients of unknown 
sex. This distribution is according with the general distribution of 
NF-1. The age distribution differs from the general distribution of 
this type of neoplasia in the general population. The average of onset 
of periampullary adenocarcinomas in NF-1 patients is lower than 
general population: four patients are younger than 40 years old, only 
four patients are older than 50, and just two of that older than 60; the 
average is 48.6 with a median range from 27-73. This datum differs 
from the literature about sporadic periampullary adenocarcinomas, not 
associated with NF1, which usually occurs after 60 years old. The most 
frequent first symptom is jaundice, present in 8 cases, as in sporadic 
neoplasms.
From a therapeutic point of view, radical surgery is possible 
in a high number of cases, as reported in the literature; in 7 cases a 
pancreatoduodenectomy was performed. Unfortunately follow-up 
reported in the literature examined is inadequate to understand the 
prognosis of this kind of neoplasia in patients with NF-1. However, 
affected by NF1. Laboratory data showed a sub-itterus (total bilirubin 
2.1 mg/dL, direct bilirubin 1.2 mg/dL) and an increase of cholestatic 
enzymesγGT1303 (ALTU/L, 150831 U/AL,P)AST. Abdominal146U/L, 
Ultrasound demonstrated dilated common bile (1.2 cm) and Wirsung 
(0.8 cm) ducts. A CT scan showed a diffuse dilatation of the biliary 
tree down to the ampulla of Vater, and revealed a 15 mm solid mass 
of the ampulla of Vater, protruding into the duodenum (Figure 1b). 
Neither pancreatic masses nor focal hepatic lesions were demonstrated. 
At ERCP an enlarged ampulla of Vater was seen, with an ulcerated 
mass protruding into the lumen of duodenum. Cannulation of the 
ampullary orifice was not performed and only biopsies samples were 
taken, revealing an infiltrating adenocarcinoma. The patient accepted 
pancreaticoduodenectomy; a Whipple operation was performed and 
13 days later the patient was discharged. Ealed a 15 mm solid mass 
of the ampulla of Vater, protruding into the duodenum. Neither 
pancreatic masses nor focal hepatic lesions were demonstrated. At 
ERCP an enlarged ampulla of Vater was seen, with an ulcerated 
mass protruding into the lumen of duodenum. Cannulation of the 
ampullary orifice was not performed and only biopsies samples were 
taken, revealing an infiltrating adenocarcinoma. The patient accepted 
pancreaticoduodenectomy; a Whipple operation was performed 
and 13 days later the patient was discharged (Figure 1c). Histologic 
analysis of the whole surgical specimen revealed an adenocarcinoma 
limited to the ampulla of Vater, without lymphonodal involvement. It 
was histologically formeded by tubular glands with some areas with 
a cribriform pattern (intestinal-type adenocarcinoma); in the context 
of the tumor a non-invasive component, with the features of tubular 
adenoma of intestinal-type, was present. The lesion of the thorax was 
histologically a typical neurofibroma (Figure 1d). Seven years after the 
operation he is in good general conditions.
Molecular analysis
A tumour specimen was frozen immediately after surgical removal. 
Genomic DNA was extracted from whole blood and frozen tumour 
tissue by standard methods. Loss of heterozygosity (LOH) analysis was 
performed using the intragenic NF1 microsatellites IVS27bAC28.4, 
IVS27bEVI-20, IVS38TG53.0 and IVS27bGXAlu [4,5]. Briefly, primers 
specific for each locus were used to amplify the repeat sequences in 
template DNA by PCR. The forward primers were labeled by 6-FAM 
or HEX and PCR products were analyzed by a model 310 automated 
sequencer (Applied Bio systems).
Results and Review of the Literature 
Neurofibromatosis consists of two clinically and genetically distinct 
Figure 2: Microsatellite analysis doesn’t show any LOH involving the NF1 gene.
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four patients has a long free-disease survival, one 22 years, one 10, 
one 7 (present case) and one 3 years. Moreover, even if a local excision 
of the tumor has been performed, the high risk of recurrence in the 
periampullary region and neoplastic degeneration of the closer mucosa 
seem to indicate that radical surgery (pancreatoduodenectomy) would 
be the best surgical choice. The most interesting aspect is the association 
between NF-1 and adenocarcinomas of the Vater ampulla. In 1987 
Jones proposed a correlation between epithelial tumors of the small 
bowel and NF-1 and three years later Kingston described a relation 
between NF-1 and epithelial neoplasia of the periampullary region, 
exclusive of carcinoids. However, there are no definite and clearly 
recognized associations between NF-1 and epithelial neoplasms of 
the gastrointestinal tract, but there are only individual case report of a 
number of uncommon primary tumors. For this reason the significance 
of this observation in still difficult to assess, even if many authors seem 
to identify a correlation between NF1 and epithelial gastrointestinal 
tumors, and in particular with periampullary tumors. Analyzing the 
pathway of cancerogenesis in NF-1 patients, several study demonstrated 
by genetic and biochemical evidence, that NF1 could be considered as a 
tumor suppressor gene. In keeping with Knudson’s “two-hit” hypothesis, 
both copies of the NF1 gene are inactivated in benign and malignant 
tumors from NF1 patients. Loss of the wild-type copy of the NF1 gene 
leading to loss of heterozygosity (LOH), as well as inactivating somatic 
point mutations within the gene, have been demonstrated in a number 
of neurofibromas and malignant peripheral nerve sheath tumors.
By microsatellite analysis, performed as described above, we 
demonstrate that the adenocarcinoma sample retained heterozygosity 
for the informative microsatellites IVS27bEVI-20 and IVS38TG53.0; 
furthermore, microsatellite analysis was unable to detect any LOH 
involving the NF1 gene (Figure 2).
Conclusion
In conclusion, although we cannot exclude a somatic NF1 point 
mutation inactivating the normal NF1 allele, our results suggest 
that Ampulla’s adenocarcinomas are an occasional event in NF1, 
accordingly to the epithelial but not neuroectodermical origin of this 
tumor [19]. However, it is important to consider that this type of tumors 
occurs more frequently and at a younger age in NF-1 patients, than in 
general population. Moreover, radical surgery is often possible and 
pancreatoduodenectomy (Whipple’s operation) is the surgery of choice, 
with the longest survival. Therefore, a correct evaluation of patients 
with NF1 who have abdominal symptoms should be more aggressive 
than in general population, especially in young patients, because this is 
the only hope to achieve a favourable result [20-22].
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